Europe Telehealth Market
Размер рынка в млрд долларов США
CAGR : %
Прогнозируемый период |
2024 –2031 |
Размер рынка (базовый год) |
USD 8.73 Million |
Размер рынка (прогнозируемый год) |
USD 29.18 Million |
CAGR |
|
Основные игроки рынка |
|
Европейский рынок телемедицины по компонентам (оборудование, телекоммуникации/услуги, программное обеспечение и интегрированные системы), способу доставки (облачный режим доставки, веб-режим доставки и режим доставки на месте), способу покупки (групповая покупка и индивидуальная покупка), применению (общая консультация, патология, неврология, кардиология, дерматология, хирургия, гинекология, ортопедия, офтальмология, радиология и другие), конечный пользователь (больничная телемедицина, врачебная телемедицина, домашняя телемедицина и другие) — отраслевые тенденции и прогноз до 2031 года.
Анализ и аналитика европейского рынка телемедицины
По данным Европейского альянса по хроническим заболеваниям, ежегодно сердечно-сосудистые заболевания (ССЗ) приводят к 3,9 миллионам смертей в Европе, при этом более 1,8 миллиона смертей регистрируется в Европейском союзе (ЕС). ССЗ являются причиной 45% всех смертей в Европе и составляют 37% от общего числа смертей в Европейском союзе.
По данным исследования рынка Data Bridge, ожидается, что объем европейского рынка телемедицины к 2031 году достигнет 29,18 млрд долларов США по сравнению с 8,73 млрд долларов США в 2023 году, а среднегодовой темп роста составит 16,7% в прогнозируемый период с 2024 по 2031 год.
Отчет Метрика |
Подробности |
Прогнозируемый период |
2024-2031 |
Базовый год |
2023 |
Исторические годы |
2022 (можно изменить на 2016–2021) |
Количественные единицы |
Доход в млрд долларов США |
Охваченные сегменты |
Компонент (оборудование, телекоммуникации/услуги, программное обеспечение и интегрированные системы), режим доставки (облачный режим доставки, веб-режим доставки и режим доставки на месте), режим покупки (групповая покупка и индивидуальная покупка), приложение (общая консультация, патология, неврология, кардиология, дерматология, хирургия, гинекология, ортопедия, офтальмология , радиология и другие), конечный пользователь (больничная телемедицина, врачебная телемедицина, домашняя телемедицина и другие) |
Страны, охваченные |
Великобритания, Германия, Италия, Франция, Испания, Швейцария, Россия, Нидерланды, Турция, Бельгия и остальная Европа |
Охваченные участники рынка |
Teladoc Health, Inc., Medtronic, Koninklijke Philips NV, Honeywell International Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., AMN Healthcare Services Inc., включая American Well (Amwell), Oracle, GCX Corporation, Aerotel Medical Systems Ltd., GE Healthcare, AMD Europe Telemedicine и Omron Healthcare Inc. среди прочих |
Определение рынка
Telehealth denotes the provision of healthcare services and medical information using telecommunications and digital technology. This encompasses a broad range of remote healthcare services, including virtual consultations, remote monitoring of patients, teletherapy, telepharmacy, and telemedicine. Through telehealth, patients can access medical care, advice, and treatment from healthcare providers remotely, often from the comfort of their own homes. This innovative approach improves access to healthcare, particularly for those in rural or underserved areas, and enhances the efficiency of care delivery. Telehealth has gained significant popularity due to its convenience, cost-effectiveness, and potential to improve health outcomes by enabling timely and accessible medical support.
Europe Telehealth Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Chronic Diseases and Conditions
Chronic diseases such as cardiovascular diseases, diabetes, and respiratory illnesses require ongoing management and monitoring, often involving frequent visits to healthcare providers. Telehealth offers a suitable and cost-effective way to manage these conditions remotely, allowing patients to receive care without the need for frequent in-person visits.
Telehealth platforms can enable patients to monitor their vital signs, track their symptoms, and communicate with healthcare providers from their homes. This not only improves convenience for patients but also allows healthcare providers to monitor patients more closely and intervene early if any issues arise. Additionally, telehealth can help reduce healthcare costs associated with chronic disease management, as it can reduce the need for hospitalizations and emergency room visits.
- Accessible and Widely Adopted M-Health Applications
Mobile health applications, often available on smartphones and tablets, allow patients to access healthcare services and information remotely. They can facilitate various telehealth services, such as virtual consultations with healthcare providers, remote monitoring of vital signs, and medication reminders. The widespread adoption of smartphones and tablets worldwide has made it easier for patients to access mHealth applications, regardless of their location. This increased accessibility has expanded the reach of telehealth services, especially in rural or underserved areas where access to traditional healthcare facilities may be limited.
Furthermore, the user-friendly interfaces and functionalities of mHealth applications have contributed to their widespread adoption among patients. These applications are often designed to be intuitive and easy to use, allowing patients to manage their health more effectively and engage with telehealth services more readily.
Restraint
- High Cost Associated with Healthcare IT Tools
The high cost associated with healthcare IT tools is a significant restraint on the Europe telehealth market. Implementing telehealth services requires substantial investment in systems, software, and hardware, which can be a barrier for many healthcare providers, especially those with limited financial resources. The cost of acquiring, implementing, and maintaining telehealth systems, software, and hardware can be prohibitively high, preventing some healthcare organizations from adopting telehealth solutions. Additionally, the complexity of integrating these IT tools with existing healthcare systems and ensuring interoperability can further increase costs. Training healthcare professionals to effectively use these tools also adds to the overall cost of implementing telehealth services.
Opportunity
- Growing Expansion of Telehealth Application
The expansion of telehealth services and the increased use of remote consultations are opening up new opportunities for telehealth market players. Telehealth platforms enable healthcare providers to assess patients remotely, provide guidance, and monitor treatment progress, offering greater accessibility and convenience for patients with musculoskeletal conditions. By eliminating geographical barriers and making healthcare more widely available, telehealth can reach patients who might otherwise face challenges accessing medical care due to distance or limited healthcare infrastructure. This growing access allows telehealth companies to cater to a broader patient base and expand their offerings. With real-time monitoring through video consultations, secure messaging, and remote monitoring devices, healthcare professionals can keep track of patients' vital signs, progress, and conditions without needing in-person visits. The seamless integration of health monitoring tools into telehealth platforms also supports personalized care management, making it easier for healthcare providers to offer high-quality, continuous care to patients. This trend presents a significant opportunity for telehealth market players to enhance their services and grow their market share.
Challenge
- Software Incompatibility Issues Due to Varying Data Standards
In the evolving landscape of the Telehealth market, the integration and exchange of data among diverse software systems, including electronic health records (EHRs), remote monitoring platforms, and healthcare provider systems, pose significant challenges. The lack of standardized data formats and protocols leads to interoperability issues, hindering effective communication and data sharing. This disparity among software systems results in fragmented information, impeding the seamless flow of data crucial for monitoring. Furthermore, the integration of data from various sources, such as wearable devices and electronic medical records, encounters hurdle due to differing proprietary formats. This complexity in consolidating and analyzing data hampers the efficiency of digital therapeutic solutions, contributing to implementation delays, increased costs, and obstacles in market growth.
Recent Developments
- In August 2023, Fresenius SE & Co. KGaA announced the FDA's 510(k) clearance for Versi HD with GuideMe Software, a fully redesigned self-guided interface for the company's VersiHD chronic home hemodialysis (HHD) equipment. The goal of VersiHD with GuideMe Software is to change how nurses and patients see HHD. This helped the company to expand its product line with availability in the market
- In April 2023, Medtronic and DaVita Inc. jointly launched Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions
- In January 2022, Evoqua Water Technologies LLC finalized the acquisition of the renal business formerly operated by Mar Cor Purification, a subsidiary of STERIS Plc. This acquisition will broaden Evoqua's service presence in North America, strengthening its position in the healthcare sector
- In December 2021, ExThera Medical and Asahi Kasei Medical Co., Ltd., a core operating company of the Asahi Kasei Group, signed an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). Under the agreement, ExThera Medical and Asahi Kasei Medical Co., Ltd. collaborated to secure regulatory approval of Seraph 100 for commercialization in Japan. This agreement, as a significant step, helped the company in the expansion of the intensive care business field
Europe Telehealth Market Scope
The Europe telehealth market is segmented into five notable segments based on component, delivery mode, mode of purchase, application, and end user.
The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Component
- Hardware
- Telecommunication/Services
- Software
- Integrated Systems
On the basis of component, the market is segmented into hardware, telecommunication/ services, software and integrated systems.
Delivery Mode
- Cloud-Based Delivery Mode
- Web-Based Delivery Mode
- On-Premise Delivery Mode
По способу доставки рынок сегментируется на облачный способ доставки, веб-способ доставки и локальный способ доставки.
Способ покупки
- Групповая покупка
- Индивидуальная покупка
По способу покупки рынок сегментируется на групповые покупки и индивидуальные покупки.
Приложение
- Общая консультация
- Патология
- Неврология
- Кардиология
- Дерматология
- Операция
- Гинекология
- Ортопедия
- Офтальмология
- Радиология
- Другие
По сфере применения рынок сегментируется на общую консультацию, патологию, неврологию, кардиологию, дерматологию, хирургию, гинекологию, ортопедию, офтальмологию, рентгенологию и другие.
Конечный пользователь
- Больничная телемедицина
- Врач Телемедицина
- Главная Телемедицина
- Другие
По признаку конечного пользователя рынок сегментируется на больничную телемедицину, врачебную телемедицину, домашнюю телемедицину и другие.
Региональный анализ/анализ европейского рынка телемедицины
Европейский рынок телемедицины разделен на пять основных сегментов в зависимости от компонента, способа доставки, способа покупки, области применения и конечного пользователя.
В данном отчете о рынке рассматриваются следующие страны: Великобритания, Германия, Италия, Франция, Испания, Швейцария, Россия, Нидерланды, Турция, Бельгия и остальные страны Европы.
Ожидается, что Великобритания будет доминировать в европейском регионе благодаря внедрению передовых технологий, надежной инфраструктуре здравоохранения и зрелому рынку.
Раздел отчета, посвященный странам, также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые продажи, заменяющие продажи, демографические данные страны, нормативные акты и импортно-экспортные пошлины, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по стране учитываются наличие и доступность европейских брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, а также влияние каналов продаж.
Анализ конкурентной среды и доли рынка телемедицины в Европе
Конкурентная среда европейского рынка телемедицины содержит сведения о конкурентах. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в НИОКР, новых рыночных инициативах, производственных площадках и объектах, сильных и слабых сторонах компании, запуске продукта, одобрении продукта, широте и широте продукта, доминировании приложений и жизненно важной кривой типа продукта. Приведенные выше данные относятся только к фокусу компании на рынке.
Среди основных игроков рынка, работающих на рынке, можно назвать Teladoc Health, Inc., Medtronic, Koninklijke Philips NV, Honeywell International Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., AMN Healthcare Services Inc., Included American Well (Amwell), Oracle, GCX Corporation, Aerotel Medical Systems Ltd., GE Healthcare, AMD Europe Telemedicine и Omron Healthcare Inc. и другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE TELEHEALTH MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 STRATEGIC DECISIONS
4.2 FOUR SEGMENTS COMPRISE THE EUROPE TELEHEALTH MARKET, BY COMPOMENT
4.3 PESTEL ANALYSIS
4.4 PORTER’S FIVE FORCES
5 REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CHRONIC DISEASES AND CONDITIONS
6.1.2 ACCESSIBLE AND WIDELY ADOPTED MHEALTH APPLICATIONS
6.1.3 GROWING DEMAND FOR TELEHEALTH IN RURAL AREA
6.2 RESTRAINTS
6.2.1 HIGH COST ASSOCIATED WITH HEALTHCARE IT TOOLS
6.2.2 INADEQUATE OR INCONSISTENT REIMBURSEMENT POLICIES
6.2.3 STRINGENT REGULATORY FRAMEWORK
6.3 OPPORTUNITIES
6.3.1 GROWING EXPANSION OF TELEHEALTH APPLICATION
6.3.2 INCREASING FOCUS ON PERSONALIZED DEVICES FOR USERS
6.3.3 INCREASING AWARENESS AMONG PEOPLE
6.4 CHALLENGES
6.4.1 SOFTWARE INCOMPATIBILITY ISSUES DUE TO VARYING DATA STANDARDS
6.4.2 RISKS OF CYBER ATTACKS ON TELEHEALTH PLATFORMS, COMPROMISING PATIENT PRIVACY
7 EUROPE TELEHEALTH MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 HARDWARE
7.2.1 MEDICAL PERIPHERAL DEVICES
7.2.1.1 BLOOD PRESSURE MONITORS
7.2.1.2 BLOOD GLUCOSE METERS
7.2.1.3 PULSE OXIMETERS
7.2.1.4 ECG MONITORS
7.2.1.5 WEIGHT SCALES
7.2.1.6 PEAK FLOW METERS
7.2.1.7 OTHERS
7.2.2 DEVICE POSITIONING SOLUTIONS
7.2.2.1 TABLET ARM
7.2.2.2 TABLE UPGRADE KIT
7.2.2.3 COMPACT TABLES
7.2.2.4 OVERBED TABLES
7.2.2.5 SURFACE MOUNTS
7.2.2.6 RAIL MOUNTS
7.2.2.7 OTHERS
7.2.3 MONITORS
7.2.4 OTHERS
7.2.5 MOBILE
7.2.5.1 CART BASED
7.2.5.1.1 VARIABLE HEIGHT
7.2.5.1.2 FIXED HEIGHT
7.2.5.2 ROLLS STAND BASED
7.2.5.2.1 VARIABLE HEIGHT
7.2.5.2.2 FIXED HEIGHT
7.2.6 FIXED
7.2.6.1 CHANNEL/WALL
7.2.6.2 COUNTER TOP
7.2.6.3 POST/POLE
7.2.6.4 OTHERS
7.3 TELECOMMUNICATION/SERVICES
7.4 SOFTWARE
7.4.1 INTEGRATED SOFTWARE
7.4.2 STANDALONE SOFTWARE
7.5 INTEGRATED SYSTEMS
8 EUROPE TELEHEALTH MARKET, BY DELIVERY MODE
8.1 OVERVIEW
8.2 CLOUD-BASED DELIVERY
8.3 WEB-BASED DELIVERY
8.4 ON-PREMISE DELIVERY MODE
9 EUROPE TELEHEALTH MARKET, BY MODE OF PURCHASE
9.1 OVERVIEW
9.2 GROUP PURCHASE
9.3 INDIVIDUAL PURCHASE
10 EUROPE TELEHEALTH MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 GENERAL CONSULTATION
10.3 PATHOLOGY
10.4 NEUROLOGY
10.5 CARDIOLOGY
10.6 DERMATOLOGY
10.7 SURGERY
10.8 GYNECOLOGY
10.9 ORTHOPEDICS
10.1 OPHTHALMOLOGY
10.11 RADIOLOGY
10.12 OTHERS
11 EUROPE TELEHEALTH MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL TELEHEALTH
11.3 PHYSICIAN TELEHEALTH
11.4 HOME TELEHEALTH
11.5 OTHERS
12 EUROPE TELEHEALTH MARKET, BY COUNTRY
12.1 EUROPE
12.1.1 U.K.
12.1.2 GERMANY
12.1.3 ITALY
12.1.4 FRANCE
12.1.5 SPAIN
12.1.6 SWITZERLAND
12.1.7 RUSSIA
12.1.8 NETHERLANDS
12.1.9 TURKEY
12.1.10 BELGIUM
12.1.11 REST OF EUROPE
13 EUROPE TELEHEALTH MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 KONINKLIJKE PHILIPS N.V.,
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 MEDTRONIC
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 HONEYWELL INTERNATIONAL INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 TELADOC HEALTH, INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 AEROTEL MEDICAL SYSTEMS
15.5.1 COMPANY SNAPSHOT
15.5.2 PRODUCT PORTFOLIO
15.5.3 RECENT DEVELOPMENT
15.6 AMERICAN WELL
15.6.1 COMPANY SNAPSHOT
15.6.2 8.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 AMN HEALTHCARE
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 F. HOFFMANN-LA ROCHE LTD
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 GCX CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVLOPMENT
15.1 GE HEALTHCARE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 OMRON HEALTHCARE, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 ORACLE
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 SERVICE PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 SIEMENS HEALTHCARE GMBH
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Список таблиц
TABLE 1 EUROPE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 2 EUROPE HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 3 EUROPE MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 EUROPE DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 5 EUROPE HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 6 EUROPE MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 7 EUROPE CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 8 EUROPE ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 9 EUROPE FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 EUROPE SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 11 EUROPE TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 12 EUROPE TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 13 EUROPE TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 14 EUROPE TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 15 EUROPE TELEHEALTH MARKET, 2022-2031 (USD MILLION)
TABLE 16 EUROPE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 17 EUROPE HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 18 EUROPE MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 EUROPE DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 20 EUROPE HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 21 EUROPE MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 22 EUROPE CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 EUROPE ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 24 EUROPE FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 25 EUROPE SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 26 EUROPE TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 27 EUROPE TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 28 EUROPE TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 29 EUROPE TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 30 U.K. TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 31 U.K. HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 U.K. MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 U.K. DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 34 U.K. HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 35 U.K. MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 36 U.K. CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 37 U.K. ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 38 U.K. FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 39 U.K. SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 U.K. TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 41 U.K. TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 42 U.K. TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 43 U.K. TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 44 GERMANY TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 45 GERMANY HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 46 GERMANY MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 GERMANY DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 GERMANY HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 49 GERMANY MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 50 GERMANY CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 GERMANY ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 GERMANY FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 GERMANY SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 GERMANY TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 55 GERMANY TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 56 GERMANY TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 57 GERMANY TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 58 ITALY TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 59 ITALY HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 ITALY MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 61 ITALY DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 62 ITALY HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 63 ITALY MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 ITALY CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 ITALY ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 66 ITALY FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 67 ITALY SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 ITALY TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 69 ITALY TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 70 ITALY TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 71 ITALY TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 72 FRANCE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 73 FRANCE HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 FRANCE MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 FRANCE DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 FRANCE HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 77 FRANCE MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 78 FRANCE CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 FRANCE ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 FRANCE FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 FRANCE SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 82 FRANCE TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 83 FRANCE TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 84 FRANCE TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 85 FRANCE TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 86 SPAIN TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 87 SPAIN HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 88 SPAIN MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 SPAIN DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 SPAIN HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 91 SPAIN MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 SPAIN CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 SPAIN ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 94 SPAIN FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 95 SPAIN SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 96 SPAIN TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 97 SPAIN TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 98 SPAIN TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 99 SPAIN TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 100 SWITZERLAND TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 101 SWITZERLAND HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 SWITZERLAND MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 103 SWITZERLAND DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 SWITZERLAND HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 105 SWITZERLAND MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 SWITZERLAND CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 SWITZERLAND ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 SWITZERLAND FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 SWITZERLAND SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 SWITZERLAND TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 111 SWITZERLAND TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 112 SWITZERLAND TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 113 SWITZERLAND TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 114 RUSSIA TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 115 RUSSIA HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 RUSSIA MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 117 RUSSIA DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 RUSSIA HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 119 RUSSIA MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 RUSSIA CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 RUSSIA ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 RUSSIA FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 RUSSIA SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 RUSSIA TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 125 RUSSIA TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 126 RUSSIA TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 127 RUSSIA TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 128 NETHERLANDS TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 129 NETHERLANDS HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 NETHERLANDS MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 NETHERLANDS DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 132 NETHERLANDS HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 133 NETHERLANDS MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 NETHERLANDS CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 135 NETHERLANDS ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 136 NETHERLANDS FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 NETHERLANDS SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 138 NETHERLANDS TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 139 NETHERLANDS TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 140 NETHERLANDS TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 141 NETHERLANDS TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 142 TURKEY TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 143 TURKEY HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 144 TURKEY MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 145 TURKEY DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 TURKEY HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 147 TURKEY MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 148 TURKEY CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 TURKEY ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 TURKEY FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 151 TURKEY SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 152 TURKEY TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 153 TURKEY TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 154 TURKEY TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 155 TURKEY TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 156 BELGIUM TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
TABLE 157 BELGIUM HARDWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 158 BELGIUM MEDICAL PERIPHERAL DEVICES IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 159 BELGIUM DEVICE POSITIONING SOLUTIONS IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 160 BELGIUM HARDWARE IN TELEHEALTH MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 161 BELGIUM MOBILE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 162 BELGIUM CART BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 163 BELGIUM ROLLS STAND BASED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 164 BELGIUM FIXED IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 BELGIUM SOFTWARE IN TELEHEALTH MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 BELGIUM TELEHEALTH MARKET, BY DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 167 BELGIUM TELEHEALTH MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 168 BELGIUM TELEHEALTH MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 169 BELGIUM TELEHEALTH MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 170 REST OF EUROPE TELEHEALTH MARKET, BY COMPONENT, 2022-2031 (USD MILLION)
Список рисунков
FIGURE 1 EUROPE TELEHEALTH MARKET: SEGMENTATION
FIGURE 2 EUROPE TELEHEALTH MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE TELEHEALTH MARKET: DROC ANALYSIS
FIGURE 4 EUROPE TELEHEALTH MARKET : EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE TELEHEALTH MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE TELEHEALTH MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE TELEHEALTH MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE TELEHEALTH MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE TELEHEALTH MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE TELEHEALTH MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY OF EUROPE TELEHEALTH MARKET
FIGURE 12 GROWING PREVALENCE OF CHRONIC DISEASES AND CONDITIONS IS DRIVING THE GROWTH OF THE EUROPE TELEHEALTH MARKET FROM 2024 TO 2031
FIGURE 13 THE CATEGORY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TELEHEALTH MARKET IN 2024 AND 2031
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC OFFSITE STERILISATION SERVICE MARKET
FIGURE 15 EUROPE TELEHEALTH MARKET: BY COMPONENT 2023
FIGURE 16 EUROPE TELEHEALTH MARKET: BY COMPONENT, 2024-2031 (USD MILLION)
FIGURE 17 EUROPE TELEHEALTH MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 18 EUROPE TELEHEALTH MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 19 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, 2023
FIGURE 20 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, 2024-2031 (USD MILLION)
FIGURE 21 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, CAGR (2024-2031)
FIGURE 22 EUROPE TELEHEALTH MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 23 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, 2023
FIGURE 24 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 25 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 26 EUROPE TELEHEALTH MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 27 EUROPE TELEHEALTH MARKET: BY APPLICATION, 2023
FIGURE 28 EUROPE TELEHEALTH MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 29 EUROPE TELEHEALTH MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 30 EUROPE TELEHEALTH MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 EUROPE TELEHEALTH MARKET: BY END USER, 2023
FIGURE 32 EUROPE TELEHEALTH MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 33 EUROPE TELEHEALTH MARKET: BY END USER, CAGR (2024-2031)
FIGURE 34 EUROPE TELEHEALTH MARKET, BY END USER, LIFELINE CURVE
FIGURE 35 EUROPE TELEHEALTH MARKET: SNAPSHOT (2023)
FIGURE 36 EUROPE TELEHEALTH MARKET: COMPANY SHARE 2023 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.